Elsevier, Digestive and Liver Disease, Volume 54, June 2022
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury
Patients with liver diseases, especially those with cirrhosis, have an increased mortality risk when infected by SARS-CoV-2 and therefore anti-SARS-CoV-2 vaccine has been recommended by leading Scientific Associations for all patients with chronic liver diseases. However, previous reports have shown a reduced antibody response following the full course of vaccination in immunosuppressed patients, including liver transplant recipients and several rheumatic diseases.
Elsevier, The Lancet, Volume 399, 5 March 2022
Elsevier, Clinical Imaging, Volume 81, January 2022
From the more than 700,000 deaths from COVID-19 in the US and the nearly 5 million worldwide, there emerge even more stories than match the statistics when one considers all of the patients' relations. While the numbers are staggering, when we humanize the stories, we are left with even greater devastation, of course. One of the stories among so many that seemed particularly salient and poignant to us was the death of Dr. Susan Moore.
Elsevier, The Lancet Public Health, Volume 7, January 2022
Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection
The COVID-19 pandemic is unprecedented. The pandemic not only induced a public health crisis, but has led to severe economic, social, and educational crises. Across economies and societies, the distributional consequences of the pandemic have been uneven. Among groups living in vulnerable conditions, the pandemic substantially magnified the inequality gaps, with possible negative implications for these individuals' long-term physical, socioeconomic, and mental wellbeing.
The 2021 China report of the Lancet Countdown on health and climate change: seizing the window of opportunity
The Lancet Public Health, Volume 6, December 2021
A Health Policy paper on the threats posed by climate change to population health in China, in the context of SDGs 3, 9, and 13, focusing specifically on how the country can manage these risks to lead a green recovery.
Elsevier, Current Opinion in Chemical Biology, Volume 65, December 2021
Drug repurposing aims to find new uses for already existing and approved drugs. We now provide a brief overview of recent developments in drug repurposing using machine learning alongside other computational approaches for comparison. We also highlight several applications for cancer using kinase inhibitors, Alzheimer's disease as well as COVID-19.
Elsevier, The Lancet Planetary Health, Volume 5, December 2021
Systems thinking in COVID-19 recovery is urgently needed to deliver sustainable development for women and girls
In low-income and middle-income countries, such as those in sub-Saharan Africa and Latin America, the COVID-19 pandemic has had substantial implications for women's wellbeing. Policy responses to the COVID-19 pandemic have highlighted the gendered aspect of pandemics; however, addressing the gendered implications of the COVID-19 pandemic comprehensively and effectively requires a planetary health perspective that embraces systems thinking to inequalities.
Elsevier, SSM - Population Health, Volume 16, December 2021
Research suggests that racial/ethnic disparities in COVID-19 in the US are largely driven by higher rates of exposure to SARS-CoV-2 among Hispanic/Latino and Black populations. Occupational exposures play a large role in structuring risk of exposure, and essential workers are at elevated risk of COVID-19 infection. At a national-level, workers categorized as “essential” and “high-risk” are disproportionately Hispanic/Latino, but we lack analysis examining local-level racial/ethnic disparities in potential occupational exposures.
The Lancet Public Health, Volume 6, November 2021
A Viewpoint on Europe's response to climate change, in the context of SDGs 12, 13, and 17, focusing specifically on the use of region-specific indicators to address the main challenges and opportunities of Europe's response in the context of public and planetary health.
Elsevier, The Lancet Planetary Health, Volume 5, November 2021
COVID-19 is disrupting and transforming the world. We argue that transformations catalysed by this pandemic should be used to improve human and planetary health and wellbeing. This paradigm shift requires decision makers and policy makers to go beyond building back better, by nesting the economic domain of sustainable development within social and environmental domains.